Pelvic implant sizing systems and methods

Information

  • Patent Grant
  • 10265152
  • Patent Number
    10,265,152
  • Date Filed
    Monday, October 15, 2012
    11 years ago
  • Date Issued
    Tuesday, April 23, 2019
    5 years ago
Abstract
Various embodiments of a mesh or implant sizing system are provided. An implant can include a gauging portion included with a support portion of the implant, to assist a surgeon in determining what size implant to insert into the pocket created in a tissue plane of the patient.
Description
FIELD OF THE INVENTION

The present invention relates generally to surgical methods and apparatus and, more specifically, to sizing or gauging features or tools for use with implant systems or kits adapted to treat incontinence or other pelvic disorders.


BACKGROUND OF THE INVENTION

Pelvic health for men and women is a medical area of increasing importance, at least in part due to an aging population. Examples of common pelvic ailments include incontinence (e.g., fecal and urinary), pelvic tissue prolapse (e.g., female vaginal prolapse), and conditions of the pelvic floor.


Urinary incontinence can further be classified as including different types, such as stress urinary incontinence (SUI), urge urinary incontinence, mixed urinary incontinence, among others. Other pelvic floor disorders include cystocele, rectocele, enterocele, and prolapse such as anal, uterine and vaginal vault prolapse. A cystocele is a hernia of the bladder, usually into the vagina and introitus. Pelvic disorders such as these can result from weakness or damage to normal pelvic support systems.


Urinary incontinence can be characterized by the loss or diminution in the ability to maintain the urethral sphincter closed as the bladder fills with urine. Male or female stress urinary incontinence (SUI) generally occurs when the patient is physically stressed.


In its severest forms, vaginal vault prolapse can result in the distension of the vaginal apex outside of the vagina. An enterocele is a vaginal hernia in which the peritoneal sac containing a portion of the small bowel extends into the rectovaginal space. Vaginal vault prolapse and enterocele represent challenging forms of pelvic disorders for surgeons. These procedures often involve lengthy surgical procedure times.


Urinary incontinence can be characterized by the loss or diminution in the ability to maintain the urethral sphincter closed as the bladder fills with urine. Male or female stress urinary incontinence (SUI) occurs when the patient is physically stressed.


There is a desire to obtain a minimally invasive yet highly effective implant or mesh, and systems, device and methods for selecting the appropriate implant to treat incontinence, and/or pelvic organ prolapse and other conditions.


SUMMARY OF THE INVENTION

The present invention describes pelvic implants and methods for treating pelvic conditions such as incontinence (various forms such as fecal incontinence, stress urinary incontinence, urge incontinence, mixed incontinence, etc.), vaginal prolapse (including various forms such as enterocele, cystocele, rectocele, apical or vault prolapse, uterine descent, etc.), and other conditions caused by muscle and ligament weakness. Embodiments of the implants can include a tissue support portion and one or more anchors, arms and the like.


The implant can include an indicator gauge or portion included with the structure of the implant, such as a mesh implant, to assist a physician in determining what size implant to insert into the pocket created in a tissue plane of the patient. The flexible gauge can deform a measurable degree when inserted into the tissue plane pocket, where the implant will eventually reside. This deformation of the gauge structure, as the implant is compressed against the margins of the tissue pocket, can cause the relative movement of gauge elements. The gauge can include indicator marks to inform the surgeon or physician whether the pocket is large enough, and what size the implant will need to be to fit appropriately in the pocket region. The present invention will lead to proper implant performance and reduced compilations. Multiple implants can be provided in a kit for the physician.


In certain embodiments, an indication gauge tool can be included in a kit or with the implant system. The tool can include flexible arms, a graduated scale portion and a handle portion. The arms of the tool, e.g., flexible polymer elements, flex and conform to the boundaries or margins of the tissue plane or tissue pocket region when inserted into that anatomical area to provide depth indications and indications as to which sized implant to use.


In other embodiments, pivoting tool can be included to aid in determining the size of implant or mesh needed for a particular tissue repair or support procedure, such as prolapse repair. The pivoting tool can also be utilized in determining if the dissection plane size is adequate for an implant. The tool can include a first handle or arm portion and a second handle or arm portion, with the handles pivotally connected at a living hinge or pivot point. The handles can take on various size and shape configurations—e.g., generally arcuate, boomerang-shaped, C-shaped, L-shaped, and the like.





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1-2 are top views of support implants, in accordance with embodiments of the present invention.



FIG. 3 is a top schematic view of a support implant having a gauge feature, in accordance with embodiments of the present invention.



FIG. 4 is a partial close-up view of a gauge feature of an implant, in accordance with embodiments of the present invention.



FIGS. 5-6 are close-up views of a gauge feature of an implant, in accordance with embodiments of the present invention.



FIGS. 7-8 are views of an indication or sizing tool, in accordance with embodiments of the present invention.



FIG. 9 is a close-up partial schematic view of an indication or sizing tool inserted in an incision, in accordance with embodiments of the present invention.



FIGS. 10-11 are views of a pivoting implant sizing tool, in accordance with embodiments of the present invention.



FIGS. 12-14 are schematic views of a pivoting implant sizing tool in use, in accordance with embodiments of the present invention.





DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS

Referring generally to FIGS. 1-14, various embodiments of an implant 10 and sizing systems, devices and methods are shown. In general, the implants 10 can include a support portion 12 and anchoring portions 16. Certain embodiments of the implant 10 can be constructed of woven or knitted polymer filaments, while other embodiments of the implant 10 can be constructed into a molded generally planar structure or from a thin generally planar film or sheet material. Examples of acceptable polymer materials available in constructing or forming the implant systems 10 and its components can include polypropylene, polyethylene, fluoropolymers or like biocompatible materials.


The implants 10, and portions thereof, could take on a myriad of different sizes, shapes and configurations depending on the particular treatment application, or deployment and support needs. For instance, certain configurations can be for uterine sparing prolapse repair and others for the post hysterectomy patient.


The various implants 10, structures, features and methods detailed herein are envisioned for use with many known implant and repair devices (e.g., for male and female), features, tools and methods, including those disclosed in U.S. Pat. Nos. 7,500,945, 7,407,480, 7,351,197, 7,347,812, 7,303,525, 7,025,063, 6,691,711, 6,648,921, and 6,612,977, International Patent Publication Nos. WO 2008/057261 and WO 2007/097994, and U.S. Patent Publication Nos. 2011/0124956, 2011/0144417, 2010/0261955, 2002/151762 and 2002/147382. Accordingly, the above-identified disclosures are fully incorporated herein by reference in their entirety.


Referring generally to 1-3, various embodiments of the implant 10 are shown. Portions of the implant 10, such as the support portion 12, can be formed or patterned by way of a polymer molding process to create a unitary homogeneous non-woven, or non-knitted, device or construct. Other embodiments can be formed from an already unitary homogeneous sheet or film via laser cutting, die cutting, stamping and like procedures.


As a result of the manufacturing process, molding or cutting, repeating cells form a lattice structure for at least the support portion 12 of the implant 10. Portions of the implant can be formed into sinusoid, or other waveform or undulating struts 14 to control elongation or compression along single or multiple axes, to define a desirable pattern density with overall reduced surface area, and to control the distribution and shaping from applied loads. The ability to mold, form or cut the struts 14 in a nearly endless array of sinusoidal or like configurations provides an implant 10 that can better tailor or mimic the anisotropic behaviors of physiological tissue.


The anchoring portions 16 can include eyelets, grommets, and/or extending tissue anchors adapted to engage with tissue to assist in positioning the implant 10 within the patient.


In certain embodiments, the patterned struts 14 define a general pinwheel configuration to further define cellular voids 19. The thickness, size and separation of the struts 14 can be modified to create an implant 10 with different surface area and cellular density attributes.


The cross section of non-woven strut members 14 can be generally circular, oval or otherwise formed to have rounded portions with exemplary embodiments of the present invention. This can be an advantage over the bunched woven or knitted filament mesh stands of conventional implants. The rounded portions of the struts 14 of the present invention provide an improved implantation feel and a consistent surface adapted to lay flat and retain its shape against target tissue, and to reduce or eliminate snagging or resistance during deployment and positioning. In addition, it provides a desirable tactile feel and surface for the physician to grasp and manipulate during implantation, and as the implant 10 passes along tissue.


Referring generally to FIGS. 3-6, various embodiments of a mesh or implant 10, such as those depicted herein and/or disclosed in the previously-incorporated references, can include a gauge or sizing indicator feature 20. The gauge feature 20 can be included with or along the structure, e.g., incorporated as part of the implant or separately attached, of the implant 10 to assist a physician in determining what size implant 10 to insert into the pocket created in a tissue plane of the patient where the implant 10 is positioned to provide the desired support treatment. Similarly, the gauge feature 20 can indicate if the tissue plane is correct, too small or too large. The gauge feature 20 can be defined in a portion of the struts 14 cells, or the support portion 12, and is adapted to deform or flex a measurable degree when inserted into the tissue plane pocket, where the implant 10, e.g., the support portion 12, will eventually reside for support. This deformation of the gauge feature 20, as the implant 10 is compressed against the margins of the tissue pocket, causes relative movement of one or more gauge elements 22. The gauge elements 22 are generally spaced from one another and can extend or measure along a distance (e.g., vertical or longitudinal) greater than the other struts 14 of the support portion 12. As such, a well-defined and readable area is provided to measure element 22 deformation and bending to indicate compression and expansion of the implant 10 within the tissue plane or pocket.


A central or other portion of the elements 22 can include a bend portion 22a. In certain embodiments, the bend portions 22a will bend inward toward one another to define a gap 23 therebetween. The degree of the bend, the location of the bend, and the gap 23 distance between the bend portions 22a can vary greatly depending on the level of granular movement and deformation that will need to be measured. In certain embodiments, the elements 22 can be constructed of a thinner or thicker material than the other or surrounding strut members 14 to control the degree of flex and provide a unique bending or flex indicator compared to the rest of the struts 14.



FIG. 5 shows a configuration of the gauge feature 20 where the elements 22 and bend portions 22a are generally not touching, thereby indicating an appropriately sized implant 10 and support portion 12 has been implanted. As such, the displacement of the elements 22 provides a positive indication that the interior pocket is large enough and acceptable. Conversely, FIG. 6 shows the gauge feature 20 in use where the bend portions 22a are touching or at least very close to one another, thereby indicating potential bunching within the tissue plane. This can inform the physician of a negative indication that the interior pocket is not large enough, e.g., the tissue pocket region needs to be increased or enlarged. Alternatively, a smaller implant 10 can be utilized if so desired.


The gauge feature 20 can include indicator mark segments, such as the bend or other structural or visual indicia, to inform the surgeon or physician whether the pocket is large enough, and what size the implant 10 will need to be to fit appropriately in the pocket region. The present invention will lead to proper implant performance and reduced complications.


In other embodiments, such as those shown in FIGS. 7-9, an indication gauge tool 30 can be included in a kit or with the implant system 10. The tool 30 can include flexible arms 32, a graduated scale portion 34 and a handle portion 36. The arms 32 of the tool 30, e.g., flexible polymer elements, flex and conform to the boundaries or margins of the tissue plane or tissue pocket region when inserted into that anatomical area. The arms 32 can include a distal hinge portion 33 and a proximal portion 35. The arms 32 can be defined by two generally C-shaped portions extending out from a bar or member operatively connected to the handle portion 36. The amount or degree of flex correspondingly alters or indicates a measurement along the scale portion 34 (FIG. 9). The scale 34 can include two portions: a general implant size scale 34a and tissue depth scale 34b.


For instance, the gauge arms 32 can deform when inserted into the tissue plane pocket where the implant 10 will eventually reside, depending on the boundaries of that pocket. For the implant size scale 34a, certain embodiments can include three size indicators: small 40, medium 42, and large 44. The appropriate implant 10 or implant 10 size is designated based on the bounds of the tissue dissection pocket and the conformity of the arms 32 within that pocket.


Additionally, the depth of the pocket area can be measured with the tissue depth scale 34b. Namely, the measurement along the scale—e.g., 3 mm to 7 mm—can indicate how deep the pocket is from the tip of the tool 30, or hinge portion 33, to the measurement along the scale 34b, including the point at which the incision I aligns with the scale 34b, as shown in FIG. 9.



FIGS. 10-14 depict a pivoting tool 50 to aid in determining the size of implant or mesh needed for a particular tissue repair or support procedure, such as prolapse repair. The tool 50 can also be utilized in determining if the dissection plane size is adequate for an implant 10. The tool 50 can include a first handle or arm portion 52 and a second handle or arm portion 54, with the handles 52, 54 pivotally connected at a living hinge or pivot point 56. The handles can take on various size and shape configurations—e.g., generally arcuate, boomerang-shaped, C-shaped, L-shaped, small, large, and the like. The first handle 52 can include a top portion 52a and the second handle can include a top portion 54a. The top portions 52a, 54a, can arc or otherwise extend away from each other—e.g., in the closed position.


When the handles are in a closed position (FIG. 10), the width of the top portion generally corresponds to the width W of the implant 10 needed or desired. A stop or like feature can prevent the handles 52, 54 from moving past this closed position. The handles pivot so that the tool 50 can be inserted into and removed from an incision I. To insert, the handles 52, 54 can start in an opened position (FIGS. 11-12) and then moved to the closed position (FIGS. 10 and 14) as the tool 50 passes through the incision, such as a vaginal or abdominal incision. For removal, the tool 50 will naturally open as it is pulled back through the incision (e.g., from resistance or biasing). One or more of the handles 52, 54 can include a scale or other measurement indicia 58 so that the physician can measure the prolapsed space to further determine what size and configuration of implant 10 is needed. The pivoting expansion and collapsibility of the tool 50 (e.g., flexible or rigid polymer materials in some embodiments) provides a relatively small tool that can pass through a small incision. Various rounded, flat and like shapes and designs can be employed along portions of the tool 50 to better facilitate insertion, opening, closing and internal cavity passage and usage. An edge or like portion of one of the handle portions 52, 54 can include a shoulder or like feature to prevent the handles 52, 54 from moving past the closed position.


As described and depicted herein, implants 10 of various sizes can be provided. In certain methods, a physician can use his or her fingers to gauge the space the implant 10 will need to fill. A visual reference representing the various implant sizes can be used to compare against the physician's fingers. For example, if the space is three fingers wide and a length from the fingertip to the second knuckle, the physician would place his or her fingers over an appropriate implant 10 to select the correct sized implant 10 for the procedure (e.g., from a kit or selection of two or more implants). In certain embodiments and procedures, a “large” implant 10 is represented by the implant 10 of FIG. 1, and a “small” implant 10 is represented in FIG. 2. Of course, various sizes and shape configurations can be selectively used and labeled to provide the necessary correlation between the support procedure and the appropriate implant 10 to be used.


In certain embodiments, as shown in FIG. 1, a large implant 10 can be provided where the distance between the two top eyelet or anchoring portions 16 be approximately 76 mm, the overall distance between the bottom eyelet or anchoring portions 16 can be approximately 54 mm, and the width or distance from the top eyelet portions to the bottom eyelet portions can be approximately 63 mm. With the smaller implant 10 of FIG. 2, the distance between the two top eyelet or anchoring portions 16 can be approximately 68 mm, the overall distance between the bottom eyelet or anchoring portions 16 can be approximately 54 mm, and the width or distance from the top eyelet portions to the bottom eyelet portions can be approximately 45 mm. Again, various other configurations and dimensional embodiments can be included without deviating from the spirit and scope of the present invention.


The physician can also use this method to determine if the dissection plane is large enough for the implant 10 selected. Numerous optional size and shape configurations can be provided in a kit to facilitate the correct implant 10 selection based on the applicable anatomical and treatment needs. Such a method can eliminate the need to introduce another tool or gauging device into the incision during the procedure.


The implant systems 10, their various components, structures, features, tools, materials and methods may have a number of suitable configurations as shown and described in the previously-incorporated references. Various methods and tools for introducing, deploying, anchoring, sizing and manipulating implants to treat incontinence and prolapse as disclosed in the previously-incorporated references are envisioned for use with the present invention as well. Further, the systems, tools, components or structures disclosed herein can be constructed of compatible materials known to those skilled in the art, including metals, polymers, and the like.


All patents, patent applications, and publications cited herein are hereby incorporated by reference in their entirety as if individually incorporated, and include those references incorporated within the identified patents, patent applications and publications.


Obviously, numerous modifications and variations of the present invention are possible in light of the teachings herein. It is therefore to be understood that within the scope of the appended claims, the invention may be practiced other than as specifically described herein.

Claims
  • 1. An implant for treating pelvic prolapse in a patient, comprising: a support portion including a plurality of undulating strut members to define a plurality of repeating cells having voids,one or more anchoring portions in operative communication with the support portion; anda gauging portion having a first flexible vertical strut element and a second vertical strut element, the second vertical strut element having a same opposing shape as the first vertical strut element, each of the first and second vertical strut elements includes two linear vertical sections and an arcuate section therebetween for each of the respective opposing strut elements, the arcuate sections facing each other and provided generally central along the respective opposing strut element, and a gap therebetween such that the arcuate sections are capable of moving toward and away from one another to provide an indication of whether an interior tissue pocket is acceptable to receive at least the support portion.
  • 2. The implant of claim 1, wherein the one or more anchoring portions includes four anchoring eyelets.
  • 3. The implant of claim 1, wherein the support portion is constructed as a unitary support portion wherein the plurality of undulating strut members are joined at and spanning out from a plurality of fixed junctions.
  • 4. The implant of claim 1, wherein at least the support portion is formed from a polymer molding process.
  • 5. The implant of claim 1, wherein the one or more anchoring portions includes one or more tissue anchors.
  • 6. The implant of claim 1, wherein the first and second flexible vertical strut elements create a void larger than the voids of the repeating cells.
  • 7. The implant of claim 1, wherein the gauging portion is defined in the support portion.
  • 8. The implant of claim 1, wherein the opposing strut elements of the gauging portion are generally thicker than the plurality of strut members of the support portion.
  • 9. An implant kit for treating pelvic prolapse in a patient, comprising: at least two implants, each of the at least two implants including: a support portion having a plurality of strut members to define a plurality of void;one or more anchoring portions in operative communication with the support portion; anda gauging portion having first and second generally flexible opposing and vertically extending strut elements to define a pair of vertical linear portions and an arcuate portion therebetween for each of the respective opposing strut elements, the arcuate portions facing each other and provided generally longitudinally central along the respective opposing strut element, and a gap therebetween such that the arcuate portions are capable of moving toward one another to provide an indication of whether an interior tissue pocket is acceptable to receive at least the support portion, wherein the arcuate portions include a generally flat tab surface facing each other, wherein the opposing strut elements of the gauging portion are generally thinner than the plurality of strut members of the support portion.
  • 10. The implant of claim 9, wherein the one or more anchoring portions includes four anchoring eyelets.
  • 11. The implant of claim 9, wherein the support portion is constructed as a unitary support portion wherein the plurality of strut members are joined at and spanning out from a plurality of fixed junctions.
  • 12. The implant of claim 9, wherein at least the support portion is formed from a polymer molding process.
  • 13. The implant of claim 9, wherein the one or more anchoring portions includes one or more tissue anchors.
  • 14. The implant of claim 9, wherein the first and second generally flexible opposing strut elements create a void larger than the voids defined by the plurality of strut members.
  • 15. The implant of claim 9, wherein the gauging portion is defined in the support portion.
  • 16. The implant of claim 9, wherein the at least two implants includes at least a first small implant and a second large implant.
  • 17. The implant of claim 9, wherein the at least two implants are formed in a unitary homogeneous sheet or film.
PRIORITY

This application claims priority to and the benefit of U.S. Provisional Patent Application No. 61/546,949, filed Oct. 13, 2011, and U.S. Provisional Patent Application No. 61/546,877, filed Oct. 13, 2011, each of which is fully incorporated herein by reference in its entirety.

US Referenced Citations (203)
Number Name Date Kind
2738790 Todt et al. Mar 1956 A
3124136 Usher Mar 1964 A
3311110 Singerman et al. Mar 1967 A
3580313 McKnight May 1971 A
3763860 Clarke Oct 1973 A
3858783 Kapitanov et al. Jan 1975 A
3924633 Cook et al. Dec 1975 A
3995619 Glatzer Dec 1976 A
4037603 Wendorff Jul 1977 A
4128100 Wendorff Dec 1978 A
4172458 Pereyra Oct 1979 A
4235238 Ogiu et al. Nov 1980 A
4246660 Wevers Jan 1981 A
4441497 Paudler Apr 1984 A
4509516 Richmond Apr 1985 A
4548202 Duncan Oct 1985 A
4632100 Somers et al. Dec 1986 A
4775380 Seedhom et al. Oct 1988 A
4865031 O'Keeffe Sep 1989 A
4873976 Schreiber Oct 1989 A
4932962 Yoon et al. Jun 1990 A
4969892 Burton et al. Nov 1990 A
5013316 Goble et al. May 1991 A
5053043 Gottesman et al. Oct 1991 A
5085661 Moss Feb 1992 A
5141520 Goble et al. Aug 1992 A
5149329 Richardson Sep 1992 A
5188636 Fedotov Feb 1993 A
5209756 Seedhom et al. May 1993 A
5250033 Evans et al. Oct 1993 A
5269783 Sander Dec 1993 A
5281237 Gimpelson Jan 1994 A
5337736 Reddy Aug 1994 A
5362294 Seitzinger Nov 1994 A
5368595 Lewis Nov 1994 A
5370650 Tovey et al. Dec 1994 A
5370662 Stone et al. Dec 1994 A
5376097 Phillips Dec 1994 A
5383904 Totakura et al. Jan 1995 A
5403328 Shallman Apr 1995 A
5413598 Moreland May 1995 A
5439467 Benderev et al. Aug 1995 A
5520700 Beyar et al. May 1996 A
5520703 Essig May 1996 A
5527342 Pietrzak et al. Jun 1996 A
5544664 Benderev et al. Aug 1996 A
5571139 Jenkins, Jr. Nov 1996 A
5591206 Moufarrege Jan 1997 A
5628756 Barker, Jr. et al. May 1997 A
5643320 Lower et al. Jul 1997 A
5669935 Rosenman et al. Sep 1997 A
5683349 Makower et al. Nov 1997 A
5709708 Thal Jan 1998 A
5725541 Anspach, III et al. Mar 1998 A
5741282 Anspach, III et al. Apr 1998 A
5807403 Beyar et al. Sep 1998 A
5842478 Benderev et al. Dec 1998 A
5919232 Chaffringeon et al. Jul 1999 A
5922026 Chin Jul 1999 A
5935122 Fourkas et al. Aug 1999 A
5944732 Raulerson et al. Aug 1999 A
5954057 Li Sep 1999 A
5972000 Beyar et al. Oct 1999 A
5980558 Wiley Nov 1999 A
5984927 Wenstrom, Jr. Nov 1999 A
5988171 Sohn et al. Nov 1999 A
5997554 Thompson Dec 1999 A
6027523 Schmieding Feb 2000 A
6036701 Rosenman Mar 2000 A
6042583 Thompson et al. Mar 2000 A
6048351 Gordon et al. Apr 2000 A
6071290 Compton Jun 2000 A
6074341 Anderson et al. Jun 2000 A
6099538 Moses Aug 2000 A
6099551 Gabbay Aug 2000 A
6099552 Adams Aug 2000 A
6106545 Egan Aug 2000 A
6117067 Gil-Vernet Sep 2000 A
6127597 Beyar et al. Oct 2000 A
6168611 Risvi Jan 2001 B1
6200330 Benderev et al. Mar 2001 B1
6241736 Sater et al. Jun 2001 B1
6328744 Harari et al. Dec 2001 B1
6387041 Harari et al. May 2002 B1
6406480 Beyar et al. Jun 2002 B1
6414179 Banville Jul 2002 B1
6482214 Sidor, Jr. et al. Nov 2002 B1
6494906 Owens Dec 2002 B1
6506190 Walshe Jan 2003 B1
6575897 Ory Jun 2003 B1
6592515 Thierfelder Jul 2003 B2
6599235 Kovac Jul 2003 B2
6599323 Melican et al. Jul 2003 B2
6602260 Harari et al. Aug 2003 B2
6612977 Staskin Sep 2003 B2
6638284 Rousseau et al. Oct 2003 B1
6648921 Anderson Nov 2003 B2
6702827 Lund Mar 2004 B1
6752814 Gellman et al. Jun 2004 B2
6755781 Gellman Jun 2004 B2
6802807 Anderson Oct 2004 B2
6884212 Thierfelder et al. Apr 2005 B2
6908473 Skiba et al. Jun 2005 B2
6911003 Anderson et al. Jun 2005 B2
6936052 Gellman et al. Aug 2005 B2
6953428 Gellman et al. Oct 2005 B2
6971986 Staskin et al. Dec 2005 B2
6974462 Sater Dec 2005 B2
6981944 Jamiolkowski Jan 2006 B2
6981983 Rosenblatt et al. Jan 2006 B1
6991597 Gellman et al. Jan 2006 B2
7014607 Gellman Mar 2006 B2
7025063 Snitkin Apr 2006 B2
7025772 Gellman et al. Apr 2006 B2
7037255 Inman May 2006 B2
7048682 Neisz et al. May 2006 B2
7056333 Walshe Jun 2006 B2
7070558 Gellman et al. Jul 2006 B2
7083637 Tannhauser Aug 2006 B1
7087065 Ulmsten et al. Aug 2006 B2
7131943 Kammerer Nov 2006 B2
7131944 Jaquetin Nov 2006 B2
7175591 Kaladelfos Feb 2007 B2
7198597 Siegel et al. Apr 2007 B2
7226408 Harari et al. Jun 2007 B2
7229404 Bouffier Jun 2007 B2
7229453 Anderson Jun 2007 B2
7235043 Gellman et al. Jun 2007 B2
7299803 Kovac Nov 2007 B2
7326213 Benderev et al. Feb 2008 B2
7347812 Mellier Mar 2008 B2
7351197 Montpetit et al. Apr 2008 B2
7357773 Watschke et al. Apr 2008 B2
7364541 Chu et al. Apr 2008 B2
7371245 Evans et al. May 2008 B2
7387634 Benderev Jun 2008 B2
7393320 Montpetit et al. Jul 2008 B2
7407480 Staskin Aug 2008 B2
7410460 Benderev Aug 2008 B2
7413540 Gellman et al. Aug 2008 B2
7494495 Delorme et al. Feb 2009 B2
7500945 Cox Mar 2009 B2
7513865 Bourne et al. Apr 2009 B2
7527588 Zaddem et al. May 2009 B2
7588598 Delorme et al. Sep 2009 B2
7637860 MacLean Dec 2009 B2
7691050 Gellman et al. Apr 2010 B2
7722527 Bouchier et al. May 2010 B2
7722528 Arnal et al. May 2010 B2
7740576 Hodroff Jun 2010 B2
7766926 Bosely et al. Aug 2010 B2
7981024 Levy Jul 2011 B2
8172745 Rosenblatt May 2012 B2
20020007222 Desai Jan 2002 A1
20020028980 Thierfelder et al. Mar 2002 A1
20020147382 Neisz et al. Oct 2002 A1
20020151909 Gellman et al. Oct 2002 A1
20020161382 Neisz Oct 2002 A1
20030004581 Rousseau Jan 2003 A1
20030010929 Prieve et al. Jan 2003 A1
20030065402 Anderson et al. Apr 2003 A1
20030176875 Anderson Sep 2003 A1
20040015057 Rocheleau et al. Jan 2004 A1
20040073235 Lund Apr 2004 A1
20040225181 Chu et al. Nov 2004 A1
20040267088 Krammerer Dec 2004 A1
20050000523 Beraud Jan 2005 A1
20050004427 Cervigni Jan 2005 A1
20050004576 Benderev Jan 2005 A1
20050131391 Chu et al. Jun 2005 A1
20050131393 Chu et al. Jun 2005 A1
20050199249 Karram Sep 2005 A1
20050245787 Cox et al. Nov 2005 A1
20050256530 Petros Nov 2005 A1
20050277806 Cristalli Dec 2005 A1
20050278037 Delorme et al. Dec 2005 A1
20050283189 Rosenblatt et al. Dec 2005 A1
20060015010 Jaffe et al. Jan 2006 A1
20060089524 Chu Apr 2006 A1
20060089525 Mamo et al. Apr 2006 A1
20060122457 Kovac Jun 2006 A1
20060173237 Jacquetin Aug 2006 A1
20060195007 Anderson Aug 2006 A1
20060195011 Arnal Aug 2006 A1
20060229596 Weiser et al. Oct 2006 A1
20070015953 MacLean Jan 2007 A1
20070161850 Harari et al. Jul 2007 A1
20070173864 Chu Jul 2007 A1
20080039678 Montpetit et al. Feb 2008 A1
20080140218 Staskin et al. Jun 2008 A1
20080300607 Meade et al. Dec 2008 A1
20090005634 Rane Jan 2009 A1
20090012353 Beyer Jan 2009 A1
20090099409 Luehrs et al. Apr 2009 A1
20090221868 Evans Sep 2009 A1
20090259092 Ogdahl et al. Oct 2009 A1
20100022822 Walshe Jan 2010 A1
20100179575 Von Pechmann et al. Jul 2010 A1
20100261950 Lund Oct 2010 A1
20100280627 Hanes, II Nov 2010 A1
20110124954 Odhahl May 2011 A1
20110174313 Von Pechmann et al. Jul 2011 A1
20120016185 Sherts et al. Jan 2012 A1
Foreign Referenced Citations (61)
Number Date Country
2002241673 Nov 2005 AU
2404459 Aug 2005 CA
2305815 Feb 1973 DE
4220283 May 1994 DE
19544162 Apr 1997 DE
0632999 Jan 1992 EP
1060714 Sep 2002 EP
2852813 Jan 2004 FR
1299162 Apr 1998 IT
1225547 Apr 1986 SU
1342486 Oct 1987 SU
WO9317635 Sep 1993 WO
WO9511631 May 1995 WO
WO9525469 Sep 1995 WO
WO9716121 May 1997 WO
WO9730638 Aug 1997 WO
WO9747244 Dec 1997 WO
WO9835606 Aug 1998 WO
WO9842261 Oct 1998 WO
WO9853746 Dec 1998 WO
WO9916381 Apr 1999 WO
WO9937217 Jul 1999 WO
WO9952450 Oct 1999 WO
WO9953844 Oct 1999 WO
WO1999059477 Nov 1999 WO
WO9959477 Nov 1999 WO
WO0064370 Feb 2000 WO
WO0013601 Mar 2000 WO
WO0040158 Jul 2000 WO
WO0057812 Oct 2000 WO
WO0074633 Dec 2000 WO
WO0106951 Feb 2001 WO
WO0139670 Jun 2001 WO
WO0156499 Aug 2001 WO
WO0234124 May 2002 WO
WO02071953 Sep 2002 WO
WO02078552 Oct 2002 WO
WO03017848 Mar 2003 WO
WO0303778 Apr 2003 WO
WO03028585 Apr 2003 WO
WO03037215 May 2003 WO
WO03041613 May 2003 WO
WO03068107 Aug 2003 WO
WO03092546 Nov 2003 WO
WO03096929 Nov 2003 WO
WO2004012626 Feb 2004 WO
WO2005079702 Sep 2005 WO
WO2005122954 Dec 2005 WO
WO2006108145 Oct 2006 WO
WO2007011341 Jan 2007 WO
WO2007016083 Feb 2007 WO
WO2007027592 Mar 2007 WO
WO2007081955 Jul 2007 WO
WO2007097994 Aug 2007 WO
WO2007146784 Dec 2007 WO
WO2007149348 Dec 2007 WO
WO2008057261 May 2008 WO
WO2008124056 Oct 2008 WO
WO2009005714 Jan 2009 WO
WO2009017680 Feb 2009 WO
WO2011082350 Jul 2011 WO
Non-Patent Literature Citations (25)
Entry
Amundsen et al., “Anatomical correction of vaginal vault prolapse by uterosacral ligament fixation in women who also require a pubovaginal sling,” the J. of Urology, vol. 169, 1770-1776, May 2003.
Cervigni et al., “The use of synthetics in the treatment of pelvic organ prolapse,” Current Opinion in Urology 2011, 11:429-435.
Eglin et al., Transobturator subvesical mesh: tolerance and short-term results of a 103 case continuous series, Service de gynecologic clinque Dhampeau 32 (Nov. 2002).
Farnsworth, B. N., “Posterior intravaginal slingplasty (infracoccygeal sacropexy) for severe posthysterectomy and vaginal vault prolapse—a preliminary report on efficacy and safety,” Int. Urogynecol J (2002) 13:4-8.
Heit et al., “Predicting treatment choice for patients with pelvic organ prolapse,” The Am. College of Obstet. & Gyn., vol. 101, No. 6, Jun. 2003.
Julian, Thomas, “The efficacy of Mariex mesh in the repair of severe, recurrent vaginal prolapse of the anterior midvaginal wall,” Am. J. Obstet. Gynecol. vol. 175, No. 6, pp. 1471-1476 (1996).
Karram et al., “Surgical Treatment of Vaginal Vault Prolapse,” Urogynecology and reconstructive pelvic surgery, Mosby (1999).
Luber, et al., “The demographics of pelvic floor disorders: current observations and future projections,” Am. J. Obstet. Gynecol. vol. 184, No. 7, pp. 1496-1504 (2001).
Mage, PH., “L-interposition d'un treillis synthetique dans la cure par voie vaginale des prolapses genitaux,” Technique chirurgicale, J. Gynecol. Obstet. Reprod. 1999:28:825-829.
Marchionni, et al., “True incidence of vaginal vault prolapse: thirteen years of experience,” J. of Reproductive Medicine, vol. 44, No. 8, pp. 679-685 (1999).
Migliari et al., “Tension-free vaginal mesh repair for anterior vaginal wall prolapse,” Eur. Urol. 2000;38:151-155.
Morley et al., “Sacrospinous ligament fixation for eversion of the vagina,” Am. J. Obstet. Gynecol., vol. 158, No. 4, pp. 871-881 (1988).
Nicita, Giulio, “A new operation for genitourinary prolapse,” The Journal of Urology, vol. 160, 741-745 (1998).
Paraiso, et al., “Laparoscopic surgery for enterocele, vaginal apex prolapse and rectocele,” Int. Urogynecol. J. 10:223-239 (1990).
Paraiso, et al., “Pelvic support defects and visceral and sexual function in women treated with sacrospinous ligament suspension and pelvic reconstruction,” Am. J. Obstet. & Gyne. vol. 175, No. 6 (1996).
Petros, P.E., “Vault Prolapse II: restoration of dynamic vaginal supports by infracoccygeal sacropexy, and axial day-case vaginal procedure,” Int. Urogynecol. J. (2001) 12:296-303.
Petros, et al., “The posterior fornix syndrome: a multiple symptom complex of pelvic pain and abnormal urinary symptoms deriving from laxity in the posterior fornix of vagina,” Scand. J. Urol Nephrol. Suppl. No. 153, pp. 89-95 (1993).
Richter, Kurt, “Massive eversion of the vagina: pathogenesis, diagnosis, and therapy of the ‘true’ prolapse of the vaginal stump,” Clinical Obstet. & Gyne., vol. 25, No. 4, pp. 897-911 (1982).
Sanz et al., “Modification abdominal sacrocolpopexy using a suture anchor system,” Journal of Reproductive Medicine, vol. 48, No. 7, pp. 496-501 (2003).
Subak et al., “Cost of pelvic organ prolapse surgery in the United States,” Am. College Obstet. & Gyne., vol. 98, No. 4, pp. 464-452 (2001).
Sullivan et al., “Total pelvic mesh repair,” Dis Colon Rectum, vol. 44, No. 6 pp. 857-864 (2001).
Swift et al., “Case-control study of etiologic factors in the development of severe pelvic organ prolapse,” Int. Urogynecol. J. 12:187-192 (2001).
Visco et al., “Vaginal mesh erosion after abdominal sacral colpopexy,” Am. J. Obstet. Gynecol vol. 184, No. 3 pp. 297-303 (2001).
Weber et al., “Anterior vaginal prolapse” review of anatomy and techniques or surgical repair, Obstet. & Gyne., vol. 89, No. 2, pp. 310-318 (1997).
Winters et al., “Abdominal sacral colpopexy and abdominal enterocele repair in the management of vaginal vault prolapse,” Urology 56 (Suppl. 6A) pp. 56-64(2000).
Related Publications (1)
Number Date Country
20130096371 A1 Apr 2013 US
Provisional Applications (2)
Number Date Country
61546949 Oct 2011 US
61546877 Oct 2011 US